DELAVIRDINE

Delavirdine (DLV) (brand name Rescriptor®) is a non-nucleoside reverse transcriptase inhibitor (NNRTI) marketed by Pfizer. It is used as part of highly active antiretroviral therapy (HAART) for the treatment of human immunodeficiency virus (HIV) type 1. It is presented as the mesylate. The recommended dosage is 400 mg, three times a day.
See more at Wikipedia.org...

Delavirdine /del·a·vir·dine/ an antiretroviral, inhibiting reverse transcriptase ; used as the mesylate salt in the treatment of HIV infection. [more]Delavirdine - Community and Resources

Noun
1. a non-nucleoside reverse transcriptase inhibitor (trade name Rescriptor) used to treat AIDS and HIV
(synonym) Rescriptor
(hypernym) non-nucleoside reverse transcriptase inhibitor, NNRTI